Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
123.64-0.68 (-0.55%)
At close: 04:00PM EDT
123.45 -0.19 (-0.15%)
After hours: 07:59PM EDT
Advertisement
Full screen
Loading interactive chart...
  • Reuters

    UPDATE 1-Pfizer CEO tests positive for COVID for a second time

    Pfizer Inc Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. "I’m feeling well and symptom free," Bourla said in a statement. Bourla, 60, back in August had contacted COVID and had started a course of the company's oral COVID-19 antiviral treatment, Paxlovid.

  • Motley Fool

    Better Growth Stock: Moderna vs. Teladoc

    It may be a bit early to establish Moderna's (NASDAQ: MRNA) and Teladoc Health's (NYSE: TDOC) lasting growth stock status by looking at the past couple of years. Moderna launched the coronavirus vaccine as its first product in 2020 -- and vaccinated a good share of the population. Teladoc saw revenue and virtual medical visits soar in the triple digits as people opted to stick close to home.

  • Yahoo Finance Video

    Moderna's COVID booster faces supply limitations after manufacturing issues

    Health reporter Anjalee Khemlani examines the shortages Moderna is experiencing in its latest COVID-19 booster shot, while also discussing vaccination options ahead of this year's flu season

Advertisement
Advertisement